Loading
EL
Elixxer Ltd. Stock: price and insider trades · Canada
Insider Decl.
75
Thresholds
n/a
Buy Volume
€389,422
50 ops. · all time
Sell Volume
€13,261
9 ops. · all time
Financial data
as of FY 2025FY ended December 2025 · cache
CA$0.04
Analyst consensus
Income statement
EBITDA-CA$1.7M
Net income-CA$3.9M0.0% margin
Valuation
Beta15.29
Balance sheet & cash
Market capCA$3.8M
Total debtCA$9.9M
Free Cash Flow-CA$705.2k
Profitability & ownership
ROA-33.9%
% insiders3.7%
% institutions84.3%
Last declaration on 23 January 2026
Declarations75 total
76,651,424 shares@ CA$0.0825Common SharesTSXSEDI:4647510
643,518 shares@ CA$1.08Common SharesTSXSEDI:3949512
19,800 shares@ CA$1.25Common SharesTSXSEDI:3941451
2,000 shares@ CA$1.296Common SharesTSXSEDI:3935680
Canonical exit: 24 Jul 2022 (T+90)
200 shares@ CA$1.16Common SharesTSXSEDI:3935677
Canonical exit: 24 Jul 2022 (T+90)
1,800 shares@ CA$1.20Common SharesTSXSEDI:3935679
Canonical exit: 24 Jul 2022 (T+90)
10,000 shares@ CA$1.50Common SharesTSXSEDI:3893834
Canonical exit: 30 May 2022 (T+90)
2,000 shares@ CA$1.1829Common SharesTSXSEDI:3893090
Canonical exit: 30 May 2022 (T+90)
4,000 shares@ CA$1.26Common SharesTSXSEDI:3892141
Canonical exit: 26 May 2022 (T+90)
2,000 shares@ CA$1.26Common SharesTSXSEDI:3892142
Canonical exit: 26 May 2022 (T+90)
700 shares@ CA$0.9929Common SharesTSXSEDI:3886005
Canonical exit: 16 May 2022 (T+90)
1,500 shares@ CA$0.985Common SharesTSXSEDI:3886006
Canonical exit: 16 May 2022 (T+90)
5,800 shares@ CA$1.00Common SharesTSXSEDI:3886004
Canonical exit: 16 May 2022 (T+90)
2,000 shares@ CA$0.9772Common SharesTSXSEDI:3886008
500 shares@ CA$1.74Common SharesTSXSEDI:3885457
Canonical exit: 11 May 2022 (T+90)
31,684 sharesCommon SharesTSXSEDI:3885554
700 shares@ CA$1.55Common SharesTSXSEDI:3885453
Canonical exit: 11 May 2022 (T+90)
491,535 sharesCommon SharesTSXSEDI:3885552
600 shares@ CA$1.70Common SharesTSXSEDI:3885455
Canonical exit: 11 May 2022 (T+90)
24,507,645 sharesCommon SharesTSXSEDI:3885451
1,200 shares@ CA$1.65Common SharesTSXSEDI:3885456
Canonical exit: 11 May 2022 (T+90)
344,276,460 sharesCommon SharesTSXSEDI:3885548
2,376,000 sharesCommon SharesTSXSEDI:3885538
154,935 sharesCommon SharesTSXSEDI:3885553
295,988,460 sharesCommon SharesTSXSEDI:3885534
25 of 75 declarations
About Elixxer Ltd.
At Elixxer Ltd., a Canadian health company listed on the Toronto stock exchange, one director makes up most of the record: Ferras Zalt files 47 of the 72 filings, 45 of them purchases. This filer makes the largest purchase, EUR 186,816 on November 14, 2019, then EUR 23,253 on August 11, 2020 and EUR 22,737 on January 29, 2020. In all, 49 purchases (35 with an amount) weigh EUR 352,889, median EUR 3,190, against 9 sales worth EUR 13,261.
The three largest sales are all by director Mazen Haddad, in March 2021: EUR 3,346 on March 23, EUR 3,321 on March 11 and EUR 3,257 on March 1; this filer files 9 times, all sales. Jeff Cheah, a director, has 4 purchases out of 4 filings. From June 30 to July 8, 2021, two filers bought EUR 13,872.
Read moreShow less
The known market capitalisation is CAD 3,810,521 and the nine filers hold 3.7% of the capital. Filings run from September 19, 2019 to May 24, 2022, with 21 in 2019, 8 in 2020, 18 in 2021 and 25 in 2022; none falls in the last twelve months. For 35 purchases a 90-day result is stored: a median of minus 30.8%, with no positive result. These are recorded past results, not a forecast.
